Rani stock forecast quantitative models suggest the "Rani

Quantitative models suggest the "Rani stock forecast" could see a 10% rally if pending trial results meet expectations. The implied volatility in options markets has risen 18%, reflecting heightened anticipation ahead of upcoming announcements. Overview: Chugai Pharmaceutical Co., Ltd. is involved in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals both in Japan and internationally, with a market cap of ¥12.08 trillion. Find detailed analytics on RANI stock on TipRanks’ Stock Analysis page . Economic conditions, particularly lower treasury yields, indirectly strengthen the "Rani stock forecast" by encouraging capital inflow into higher-risk growth sectors like biotech.